Intensity Therapeutics, Inc. financial data

Symbol
INTS on Nasdaq
Location
1 Enterprise Drive, Suite 430, Shelton, CT
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 184 % -41.7%
Debt-to-equity 72.8 % +79.5%
Return On Equity -371 % -76.8%
Return On Assets -215 % -43.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60.1M shares +333%
Common Stock, Shares, Outstanding 49.1M shares +254%
Entity Public Float 45.3M USD +106%
Common Stock, Value, Issued 5K USD +400%
Weighted Average Number of Shares Outstanding, Basic 43M shares +212%
Weighted Average Number of Shares Outstanding, Diluted 43M shares +212%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.25M USD -29.8%
General and Administrative Expense 4.79M USD -25.3%
Operating Income (Loss) -12M USD +28.1%
Net Income (Loss) Attributable to Parent -11.7M USD +27.8%
Earnings Per Share, Basic 0 USD/shares -85.3%
Earnings Per Share, Diluted 0 USD/shares -85.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.07M USD +154%
Marketable Securities, Current 8.96M USD
Cash, Cash Equivalents, and Short-term Investments 7.1M USD
Other Assets, Current 6K USD -92.1%
Assets, Current 8.19M USD +116%
Operating Lease, Right-of-Use Asset 103K USD -19.5%
Other Assets, Noncurrent 1.3M USD -0.15%
Assets 9.59M USD +83.9%
Accounts Payable, Current 1.68M USD +212%
Employee-related Liabilities, Current 15K USD -97.6%
Accrued Liabilities, Current 561K USD -67.9%
Liabilities, Current 2.28M USD -1.77%
Operating Lease, Liability, Noncurrent 87K USD -25.6%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 2.36M USD -2.92%
Retained Earnings (Accumulated Deficit) -75.3M USD -18.5%
Stockholders' Equity Attributable to Parent 7.22M USD +160%
Liabilities and Equity 9.59M USD +83.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.99M USD +54.4%
Net Cash Provided by (Used in) Financing Activities 328K USD +4000%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 135M shares 0%
Common Stock, Shares, Issued 49.1M shares +254%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.66M USD -51.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.07M USD +154%
Deferred Tax Assets, Valuation Allowance 16.2M USD +35.1%
Deferred Tax Assets, Gross 16.3M USD +35%
Operating Lease, Liability 118K USD -18.6%
Lessee, Operating Lease, Liability, to be Paid 131K USD -21.6%
Operating Lease, Liability, Current 31K USD +10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 39K USD +5.41%
Lessee, Operating Lease, Liability, to be Paid, Year One 37K USD +2.78%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13K USD -40.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 39K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 10.2M USD +18.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 39K USD 0%
Operating Lease, Payments 47K USD 0%
Additional Paid in Capital 82.6M USD +24.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 33K USD -15.4%
Share-based Payment Arrangement, Expense 2.39M USD -9.73%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%